Cargando…

The Analysis of bcl-2 in Association with p53 and Ki-67 in Triple Negative Breast Cancer and Other Molecular Subtypes in Ghana

BACKGROUND: Little is known about the role of apoptosis in the tumorigenesis and prognosis of breast cancer in Ghana. Chemotherapeutic drug efficacy partially relates to apoptosis induction, rendering it a vital target in cancer therapy with unique biomarker opportunities that have not been exploite...

Descripción completa

Detalles Bibliográficos
Autores principales: Ameh-Mensah, Charity, Duduyemi, Babatunde Moses, Bedu-Addo, Kweku, Atta Manu, Elijah, Opoku, Francis, Titiloye, Nicholas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8195641/
https://www.ncbi.nlm.nih.gov/pubmed/34188682
http://dx.doi.org/10.1155/2021/7054134
_version_ 1783706533128830976
author Ameh-Mensah, Charity
Duduyemi, Babatunde Moses
Bedu-Addo, Kweku
Atta Manu, Elijah
Opoku, Francis
Titiloye, Nicholas
author_facet Ameh-Mensah, Charity
Duduyemi, Babatunde Moses
Bedu-Addo, Kweku
Atta Manu, Elijah
Opoku, Francis
Titiloye, Nicholas
author_sort Ameh-Mensah, Charity
collection PubMed
description BACKGROUND: Little is known about the role of apoptosis in the tumorigenesis and prognosis of breast cancer in Ghana. Chemotherapeutic drug efficacy partially relates to apoptosis induction, rendering it a vital target in cancer therapy with unique biomarker opportunities that have not been exploited. Aberrations in this pathway are central to tumorigenesis, tumor progression, overall tumor growth, and regression during treatment therapies. Antiapoptotic bcl-2 (gene) and p53 are known to play roles in apoptosis while Ki-67 is a proliferative marker. The aim of our study is to determine the association of bcl-2 (protein) with p53 and Ki-67 in 203 consecutive breast cancer cases over a 10-year period. METHOD: A retrospective cross-sectional study on archival FFPE tissue blocks over a 9-year period with abstraction of clinicopathologic data. Two hundred and three consecutive and suitable FFPE blocks were selected for tissue microarray (TMA) construction, and IHC (bcl-2 (protein), Ki-67, p53, cyclin D, pan cytokeratins A and E, ER, PR, and HER2/neu) was done. Expressions of bcl-2 (protein), p53, and Ki-67 were related to histological grade, lymphovascular invasion, and molecular subtypes. SPSS version 23 was used to analyze results. RESULTS: Most of our cases were in the fifth decade of life (31%); invasive carcinoma of no special type (NST) was predominant (87%); histological grade III (38%) was the highest; and Luminal A (19.8%), Luminal B (9.9%), HER2 (16%), and TNBC (54.3%) constituted the molecular classes. bcl-2 expression was found in 38% of the cases. Our cases also showed mutation in p53 (36.7%) and ki-67 expression (62.5%). bcl-2 (protein) and p53 significantly correlated with Luminal B and TNBC (p < 0.01). Ki-67 also correlated significantly with Luminal A and B and HER2 overexpression (p < 0.01). Premenopausal age (40–49) and histological grade inversely correlated with bcl-2 (protein) expression. p53 statistically correlated with Ki-67 (p < 0.05). CONCLUSION: Our results show high expression of bcl-2 (protein) suggesting an important role of apoptosis in Ghanaian breast cancer cases. bcl-2 (protein), p53, and Ki-67 expressions emerged interdependently from this research and can thus be manipulated in prediction and prognosis of breast cancers in our setting.
format Online
Article
Text
id pubmed-8195641
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-81956412021-06-28 The Analysis of bcl-2 in Association with p53 and Ki-67 in Triple Negative Breast Cancer and Other Molecular Subtypes in Ghana Ameh-Mensah, Charity Duduyemi, Babatunde Moses Bedu-Addo, Kweku Atta Manu, Elijah Opoku, Francis Titiloye, Nicholas J Oncol Research Article BACKGROUND: Little is known about the role of apoptosis in the tumorigenesis and prognosis of breast cancer in Ghana. Chemotherapeutic drug efficacy partially relates to apoptosis induction, rendering it a vital target in cancer therapy with unique biomarker opportunities that have not been exploited. Aberrations in this pathway are central to tumorigenesis, tumor progression, overall tumor growth, and regression during treatment therapies. Antiapoptotic bcl-2 (gene) and p53 are known to play roles in apoptosis while Ki-67 is a proliferative marker. The aim of our study is to determine the association of bcl-2 (protein) with p53 and Ki-67 in 203 consecutive breast cancer cases over a 10-year period. METHOD: A retrospective cross-sectional study on archival FFPE tissue blocks over a 9-year period with abstraction of clinicopathologic data. Two hundred and three consecutive and suitable FFPE blocks were selected for tissue microarray (TMA) construction, and IHC (bcl-2 (protein), Ki-67, p53, cyclin D, pan cytokeratins A and E, ER, PR, and HER2/neu) was done. Expressions of bcl-2 (protein), p53, and Ki-67 were related to histological grade, lymphovascular invasion, and molecular subtypes. SPSS version 23 was used to analyze results. RESULTS: Most of our cases were in the fifth decade of life (31%); invasive carcinoma of no special type (NST) was predominant (87%); histological grade III (38%) was the highest; and Luminal A (19.8%), Luminal B (9.9%), HER2 (16%), and TNBC (54.3%) constituted the molecular classes. bcl-2 expression was found in 38% of the cases. Our cases also showed mutation in p53 (36.7%) and ki-67 expression (62.5%). bcl-2 (protein) and p53 significantly correlated with Luminal B and TNBC (p < 0.01). Ki-67 also correlated significantly with Luminal A and B and HER2 overexpression (p < 0.01). Premenopausal age (40–49) and histological grade inversely correlated with bcl-2 (protein) expression. p53 statistically correlated with Ki-67 (p < 0.05). CONCLUSION: Our results show high expression of bcl-2 (protein) suggesting an important role of apoptosis in Ghanaian breast cancer cases. bcl-2 (protein), p53, and Ki-67 expressions emerged interdependently from this research and can thus be manipulated in prediction and prognosis of breast cancers in our setting. Hindawi 2021-06-03 /pmc/articles/PMC8195641/ /pubmed/34188682 http://dx.doi.org/10.1155/2021/7054134 Text en Copyright © 2021 Charity Ameh-Mensah et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Ameh-Mensah, Charity
Duduyemi, Babatunde Moses
Bedu-Addo, Kweku
Atta Manu, Elijah
Opoku, Francis
Titiloye, Nicholas
The Analysis of bcl-2 in Association with p53 and Ki-67 in Triple Negative Breast Cancer and Other Molecular Subtypes in Ghana
title The Analysis of bcl-2 in Association with p53 and Ki-67 in Triple Negative Breast Cancer and Other Molecular Subtypes in Ghana
title_full The Analysis of bcl-2 in Association with p53 and Ki-67 in Triple Negative Breast Cancer and Other Molecular Subtypes in Ghana
title_fullStr The Analysis of bcl-2 in Association with p53 and Ki-67 in Triple Negative Breast Cancer and Other Molecular Subtypes in Ghana
title_full_unstemmed The Analysis of bcl-2 in Association with p53 and Ki-67 in Triple Negative Breast Cancer and Other Molecular Subtypes in Ghana
title_short The Analysis of bcl-2 in Association with p53 and Ki-67 in Triple Negative Breast Cancer and Other Molecular Subtypes in Ghana
title_sort analysis of bcl-2 in association with p53 and ki-67 in triple negative breast cancer and other molecular subtypes in ghana
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8195641/
https://www.ncbi.nlm.nih.gov/pubmed/34188682
http://dx.doi.org/10.1155/2021/7054134
work_keys_str_mv AT amehmensahcharity theanalysisofbcl2inassociationwithp53andki67intriplenegativebreastcancerandothermolecularsubtypesinghana
AT duduyemibabatundemoses theanalysisofbcl2inassociationwithp53andki67intriplenegativebreastcancerandothermolecularsubtypesinghana
AT beduaddokweku theanalysisofbcl2inassociationwithp53andki67intriplenegativebreastcancerandothermolecularsubtypesinghana
AT attamanuelijah theanalysisofbcl2inassociationwithp53andki67intriplenegativebreastcancerandothermolecularsubtypesinghana
AT opokufrancis theanalysisofbcl2inassociationwithp53andki67intriplenegativebreastcancerandothermolecularsubtypesinghana
AT titiloyenicholas theanalysisofbcl2inassociationwithp53andki67intriplenegativebreastcancerandothermolecularsubtypesinghana
AT amehmensahcharity analysisofbcl2inassociationwithp53andki67intriplenegativebreastcancerandothermolecularsubtypesinghana
AT duduyemibabatundemoses analysisofbcl2inassociationwithp53andki67intriplenegativebreastcancerandothermolecularsubtypesinghana
AT beduaddokweku analysisofbcl2inassociationwithp53andki67intriplenegativebreastcancerandothermolecularsubtypesinghana
AT attamanuelijah analysisofbcl2inassociationwithp53andki67intriplenegativebreastcancerandothermolecularsubtypesinghana
AT opokufrancis analysisofbcl2inassociationwithp53andki67intriplenegativebreastcancerandothermolecularsubtypesinghana
AT titiloyenicholas analysisofbcl2inassociationwithp53andki67intriplenegativebreastcancerandothermolecularsubtypesinghana